CRUS
Cirrus Logic, Inc.
CRUS trails on the overall score without a compensating advantage in the available component scores.
PLTR
Palantir Technologies Inc.
PLTR has the edge over CRUS overall, supported by stronger modeled upside and stronger valuation.
CRUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CRUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
CRUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 15x | $122 | — |
| Cheap | 16x | $128 | +4.8% |
| Fair | 21x | $168 | +38% |
| Expensive | 28x | $219 | +80% |
Historical ranges are pointers, not guarantees.
CRUS's PE is in its cheap range at 15x.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over CRUS in the historical PE scenario, which offers more potential upside but is not a forecast.
CRUS Forward outlook
There aren't enough analyst estimates for CRUS to show an outlook.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for PLTR, with profitability improving.
CRUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $7.93 | +13% |
| Q2 2026 | $8.18 | +28% |
| Q1 2026 | $7.85 | +31% |
| Q4 2025 | $7.58 | +38% |
| Q3 2025 | $7.03 | +20% |
| Q2 2025 | $6.38 | +19% |
| Q1 2025 | $6.00 | +22% |
| Q4 2024 | $5.48 | +73% |
CRUS's earnings per share have climbed steadily: $7.93 over the past year, up 13% from the year before, and higher year over year for 11 quarters in a row.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over CRUS on earnings, with stronger typical year-over-year growth.
CRUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $559.5M | -0.3% |
| Q2 2026 | $459.7M | +13% |
| Q1 2026 | $448.5M | +5.7% |
| Q4 2025 | $580.6M | +4.5% |
| Q3 2025 | $561M | +3.5% |
| Q2 2025 | $407.3M | +8.9% |
| Q1 2025 | $424.5M | +14% |
| Q4 2024 | $555.7M | -10% |
CRUS's revenue is growing: $559M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | -2.1 points |
| Q2 2026 | 18% | +0.6 points |
| Q1 2026 | 20% | -0.1 points |
| Q4 2025 | 26% | +0.1 points |
| Q3 2025 | 26% | +1.5 points |
| Q2 2025 | 18% | +5.3 points |
| Q1 2025 | 20% | +6.2 points |
| Q4 2024 | 26% | -0.8 points |
CRUS's operating margin was 24% last quarter, down 2.1 points from the same quarter a year ago.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over CRUS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over CRUS on profitability, with a higher operating margin.
CRUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $42.5M | -52% |
| Q2 2026 | $49M | -57% |
| Q1 2026 | $149M | +17% |
| Q4 2025 | $285.7M | +35% |
| Q3 2025 | $88.3M | +1489% |
| Q2 2025 | $113.5M | +47% |
| Q1 2025 | $127M | -22% |
| Q4 2024 | $211.9M | -30% |
CRUS generated $526M in free cash flow over the past year, down 2.7% from the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over CRUS on cash flow, with more consistent year-over-year improvement.
CRUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -872K shares |
| 1 year | -3% | -1.6M shares |
| 3 years | -8.5% | -4.8M shares |
| 5 years | -13% | -8M shares |
| Available history | -15% | -9M shares |
CRUS has the edge over PLTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $128.5M |
| Q2 2026 | $31.5M |
| Q1 2026 | $70M |
| Q4 2025 | $70M |
| Q3 2025 | $40M |
| Q2 2025 | $100M |
| Q1 2025 | $100M |
| Q4 2024 | $70M |
CRUS spent $300M buying back its own shares over the past year, down 3.2% from the year before.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
CRUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -1.6x | Net Cash |
| Q4 2025 | -1.5x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
CRUS has the edge over PLTR on leverage, with a lower net debt burden relative to earnings.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has more cash than debt.
CRUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 41.1 | Neutral |
CRUS's weekly RSI is 47 (neutral) and its Stochastic is 41 (neutral).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
CRUS PE vs Technology Sector
| Metric | CRUS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 28x | 45% below |
| PE % | 15 | 35 | 20 pts below |
CRUS has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
CRUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $114.2 | 6.6% above |
| 20 week MA | $121.6 | 0.1% above |
| 50 week MA | $135.7 | 10% below |
| 100 week MA | $121.5 | 0.2% above |
| 200 week MA | $108.8 | 12% above |
CRUS's trend is mixed: it's above four of its five weekly moving averages, and 12% above its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR's trend is up, with a small recent dip: it's below only its 8-week average, and 106% above its 200-week average.
CRUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $83.4 | $81.0 | -2.9% |
| 2021 | $81.0 | $91.5 | +13% |
| 2022 | $91.5 | $75.0 | -18% |
| 2023 | $75.0 | $83.2 | +11% |
| 2024 | $83.2 | $101.9 | +22% |
| 2025 | $101.9 | $120.9 | +19% |
| 2026 YTD | $120.9 | $121.7 | +0.7% |
CRUS has the edge over PLTR on returns for 2026, with the stronger performance.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.